Join
Live feed
·
INSIDERFilingvia Quantisnow
Amneal Pharmaceuticals Inc. logo

President & Co-CEO Patel Chirag K. covered exercise/tax liability with 350,978 shares and converted options into 886,468 shares, increasing direct ownership by 62% to 1,393,470 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AMRX (Amneal Pharmaceuticals Inc.) and more on Quantisnow.